Shilpa Medicare Limited (BOM:530549)
323.30
-8.30 (-2.50%)
At close: Feb 12, 2026
Shilpa Medicare Revenue
Shilpa Medicare had revenue of 4.10B INR in the quarter ending December 31, 2025, with 28.31% growth. This brings the company's revenue in the last twelve months to 14.33B, up 14.78% year-over-year. In the fiscal year ending March 31, 2025, Shilpa Medicare had annual revenue of 12.88B with 11.69% growth.
Revenue (ttm)
14.33B
Revenue Growth
+14.78%
P/S Ratio
4.45
Revenue / Employee
14.36M
Employees
998
Market Cap
63.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.88B | 1.35B | 11.69% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | 9.02B | -66.41M | -0.73% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 22.27B |
| Neuland Laboratories | 15.75B |
| Sudeep Pharma | 6.17B |
| Bajaj HealthCare | 6.12B |
| NGL Fine-Chem | 4.08B |
| Gujarat Themis Biosyn | 1.59B |
| Infinium Pharmachem | 1.57B |
| Anlon Healthcare | 1.44B |
Shilpa Medicare News
- 4 days ago - Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83% - Business Upturn
- 7 days ago - Shilpa Medicare Ltd (BOM:530549) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 7 days ago - Q3 2026 Shilpa Medicare Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Shilpa Medicare Q3 Results: Revenue jumps 28.3% YoY to Rs 409.73 crore, net profit up 40.3% - Business Upturn
- 9 days ago - Pharma sector stocks today, Feb 4: Suven Life Sciences jumps 9%, Aarti Drugs falls 6%, Shilpa Medicare up 2.80%, Mankind Pharma down 2.92% - Business Upturn
- 12 days ago - Pharma sector stocks today, Feb 1: Shilpa Medicare rally 8%, Sun Pharma up 3%, Aurobindo Pharma falls 2.21% - Business Upturn
- 16 days ago - Shilpa Medicare shares in focus after subsidiary secures key US FDA orphan drug milestone - Business Upturn
- 2 months ago - Shilpa Medicare receives Initial Authorization for Rotigotine transdermal patch in European - Business Upturn